269 related articles for article (PubMed ID: 15751983)
1. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
Schmidt JJ; Stafford RG
Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
[TBL] [Abstract][Full Text] [Related]
2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
Chen S; Wan HY
Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
Agarwal R; Binz T; Swaminathan S
Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease.
Oost T; Sukonpan C; Brewer M; Goodnough M; Tepp W; Johnson EA; Rich DH
Biopolymers; 2003; 71(6):602-19. PubMed ID: 14991672
[TBL] [Abstract][Full Text] [Related]
6. Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.
Agarwal R; Schmidt JJ; Stafford RG; Swaminathan S
Nat Struct Mol Biol; 2009 Jul; 16(7):789-94. PubMed ID: 19543288
[TBL] [Abstract][Full Text] [Related]
7. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
Foran P; Shone CC; Dolly JO
Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
[TBL] [Abstract][Full Text] [Related]
8. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity.
Rowe B; Schmidt JJ; Smith LA; Ahmed SA
Anal Biochem; 2010 Jan; 396(2):188-93. PubMed ID: 19782037
[TBL] [Abstract][Full Text] [Related]
9. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
Cornille F; Roques BP
J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
[TBL] [Abstract][Full Text] [Related]
10. Substrate recognition strategy for botulinum neurotoxin serotype A.
Breidenbach MA; Brunger AT
Nature; 2004 Dec; 432(7019):925-9. PubMed ID: 15592454
[TBL] [Abstract][Full Text] [Related]
11. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.
Shone CC; Roberts AK
Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446
[TBL] [Abstract][Full Text] [Related]
12. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the protease from Clostridium botulinum serotype C responsible for nicking in botulinum neurotoxin complex.
Suzuki T; Yoneyama T; Miyata K; Mikami A; Chikai T; Inui K; Kouguchi H; Niwa K; Watanabe T; Miyazaki S; Ohyama T
Biochem Biophys Res Commun; 2009 Feb; 379(2):309-13. PubMed ID: 19103155
[TBL] [Abstract][Full Text] [Related]
14. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B.
Sikorra S; Henke T; Swaminathan S; Galli T; Binz T
J Mol Biol; 2006 Mar; 357(2):574-82. PubMed ID: 16430921
[TBL] [Abstract][Full Text] [Related]
15. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
16. Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity.
Anne C; Turcaud S; Blommaert AG; Darchen F; Johnson EA; Roques BP
Chembiochem; 2005 Aug; 6(8):1375-80. PubMed ID: 15988765
[TBL] [Abstract][Full Text] [Related]
17. A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.
Purcell AL; Hoard-Fruchey HM
Anal Biochem; 2007 Jul; 366(2):207-17. PubMed ID: 17548044
[TBL] [Abstract][Full Text] [Related]
18. Botulinum Neurotoxin F Subtypes Cleaving the VAMP-2 Q
Sikorra S; Skiba M; Dorner MB; Weisemann J; Weil M; Valdezate S; Davletov B; Rummel A; Dorner BG; Binz T
Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30071628
[TBL] [Abstract][Full Text] [Related]
19. Specificity of botulinum protease for human VAMP family proteins.
Yamamoto H; Ida T; Tsutsuki H; Mori M; Matsumoto T; Kohda T; Mukamoto M; Goshima N; Kozaki S; Ihara H
Microbiol Immunol; 2012 Apr; 56(4):245-53. PubMed ID: 22289120
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
